Why One Pilot Reached So Few Firms
The Commercialization Assistance Pilot Program (CAPP) was created to help SBIR-funded technologies cross a difficult transition, but the Government Accountability Office’s review found that the pilot operated in a much narrower institutional space than its legal wording might suggest. This chapter examines what happened when CAPP met agency structures, budgets, existing programs, and small-business circumstances. The result is a useful distinction: limited reach does not prove that the pilot failed, and reported progress does not prove that it caused commercialization.
A legal requirement met an uneven agency landscape
CAPP was required for SBIR participating agencies unless the Small Business Administration (SBA) granted an exception for a sufficiently similar program. In principle, that sounds like a broad national mechanism. In practice, eligibility depended on an earlier event that many agencies did not regularly offer: a sequential Phase II award. A business could qualify for CAPP only after receiving a Phase II and a sequential Phase II for the same project. Agencies without that earlier continuation had no pool of businesses eligible to receive the pilot’s additional award.
GAO’s headline finding was that, by 2024, only one agency component had implemented CAPP: the Department of Energy’s Office of Science. The report says that this component made seven CAPP awards from fiscal years 2019 through 2024. Its award table separately lists ten selected awardees, including three selected in fiscal year 2024 whose award details had not been finalized when the report was completed. Those are not contradictory totals if they are kept as different categories. “Seven awards” describes awards made through the period; “ten selected awardees” includes the later selections whose final details were still pending.
The DOE population was not large enough to resemble a mass commercialization pipeline. DOE received 21 CAPP applications. GAO identified 136 unique small businesses working on 195 SBIR projects that were eligible to apply to the Office of Science during the period it examined. This tells us how the eligibility chain narrowed the field: thousands of SBIR awards existed across the program, but only businesses with a particular history of sequential Phase II support at this component could enter CAPP’s application process.
Most other agencies did not implement CAPP for different reasons. Many did not offer sequential Phase II awards at all, so they did not work with businesses eligible for CAPP. Two agencies offered sequential Phase II awards only infrequently and said their pools of eligible applicants were too small to make implementation practical. This is a structural explanation, not an evaluation of the technologies those agencies funded. The law defined a program around one kind of prior award, while agencies organized their R&D portfolios in different ways.
Some agencies had another route to commercialization support. NASA and the National Institutes of Health applied to SBA for exceptions, and SBA determined that their collections of programs were sufficiently similar to CAPP. NASA cited several mechanisms, including commercialization-readiness support, a Phase II extended award, and innovation training. NIH pointed to its own continuation and commercialization-assistance activities.